Cargando…

Enhancement of Immune Responses by Guanosine-Based Particles in DNA Plasmid Formulations against Infectious Diseases

Immunogenicity of DNA vaccines can be efficiently improved by adding adjuvants into their formulations. In this regard, the application of nano- and microparticles as vaccines adjuvants, or delivery systems, provides a powerful tool in designing modern vaccines. In the present study, we examined the...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos, Saritza, Ramírez, Maité, Miranda, Eric, Reyes, Nelson, Martínez, Osmarie, Acosta-Santiago, Maxier, Rivera, José M., Otero, Miguel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556318/
https://www.ncbi.nlm.nih.gov/pubmed/31240233
http://dx.doi.org/10.1155/2019/3409371
_version_ 1783425310407000064
author Santos, Saritza
Ramírez, Maité
Miranda, Eric
Reyes, Nelson
Martínez, Osmarie
Acosta-Santiago, Maxier
Rivera, José M.
Otero, Miguel
author_facet Santos, Saritza
Ramírez, Maité
Miranda, Eric
Reyes, Nelson
Martínez, Osmarie
Acosta-Santiago, Maxier
Rivera, José M.
Otero, Miguel
author_sort Santos, Saritza
collection PubMed
description Immunogenicity of DNA vaccines can be efficiently improved by adding adjuvants into their formulations. In this regard, the application of nano- and microparticles as vaccines adjuvants, or delivery systems, provides a powerful tool in designing modern vaccines. In the present study, we examined the role of “Supramolecular Hacky Sacks” (SHS) particles, made via the hierarchical self-assembly of a guanosine derivative, as a novel immunomodulator for DNA plasmid preparations. These plasmids code for the proteins HIV-1 Gag (pGag), the wild-type vaccinia virus Western Reserve A27 (pA27L), or a codon-optimized version of the latter (pOD1A27Lopt), which is also linked to the sequence of the outer domain-1 (OD1) from HIV-1 gp120 protein. We evaluated the enhancement of the immune responses generated by our DNA plasmid formulations in a murine model through ELISpot and ELISA assays. The SHS particles increased the frequencies of IFN-γ-producing cells in mice independently immunized with pGag and pA27L plasmids. Moreover, the addition of SHS to pGag and pA27L DNA plasmid formulations enhanced the production of IFN-γ (Th1-type) over IL-4 (Th2-type) cellular immune responses. Furthermore, pGag and pA27L plasmids formulated with SHS, triggered the production of antigen-specific IgG in mice, especially the IgG2a isotype. However, no improvement of either of those adaptive immune responses was observed in mice receiving pOD1A27Lopt+SHS. Here, we demonstrated that SHS particles have the ability to improve both arms of adaptive immunity of plasmid coding “wild-type” antigens without additional strategies to boost their immunogenicity. To the best of our knowledge, this is the first report of SHS guanosine-based particles as DNA plasmid adjuvants.
format Online
Article
Text
id pubmed-6556318
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-65563182019-06-25 Enhancement of Immune Responses by Guanosine-Based Particles in DNA Plasmid Formulations against Infectious Diseases Santos, Saritza Ramírez, Maité Miranda, Eric Reyes, Nelson Martínez, Osmarie Acosta-Santiago, Maxier Rivera, José M. Otero, Miguel J Immunol Res Research Article Immunogenicity of DNA vaccines can be efficiently improved by adding adjuvants into their formulations. In this regard, the application of nano- and microparticles as vaccines adjuvants, or delivery systems, provides a powerful tool in designing modern vaccines. In the present study, we examined the role of “Supramolecular Hacky Sacks” (SHS) particles, made via the hierarchical self-assembly of a guanosine derivative, as a novel immunomodulator for DNA plasmid preparations. These plasmids code for the proteins HIV-1 Gag (pGag), the wild-type vaccinia virus Western Reserve A27 (pA27L), or a codon-optimized version of the latter (pOD1A27Lopt), which is also linked to the sequence of the outer domain-1 (OD1) from HIV-1 gp120 protein. We evaluated the enhancement of the immune responses generated by our DNA plasmid formulations in a murine model through ELISpot and ELISA assays. The SHS particles increased the frequencies of IFN-γ-producing cells in mice independently immunized with pGag and pA27L plasmids. Moreover, the addition of SHS to pGag and pA27L DNA plasmid formulations enhanced the production of IFN-γ (Th1-type) over IL-4 (Th2-type) cellular immune responses. Furthermore, pGag and pA27L plasmids formulated with SHS, triggered the production of antigen-specific IgG in mice, especially the IgG2a isotype. However, no improvement of either of those adaptive immune responses was observed in mice receiving pOD1A27Lopt+SHS. Here, we demonstrated that SHS particles have the ability to improve both arms of adaptive immunity of plasmid coding “wild-type” antigens without additional strategies to boost their immunogenicity. To the best of our knowledge, this is the first report of SHS guanosine-based particles as DNA plasmid adjuvants. Hindawi 2019-05-22 /pmc/articles/PMC6556318/ /pubmed/31240233 http://dx.doi.org/10.1155/2019/3409371 Text en Copyright © 2019 Saritza Santos et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Santos, Saritza
Ramírez, Maité
Miranda, Eric
Reyes, Nelson
Martínez, Osmarie
Acosta-Santiago, Maxier
Rivera, José M.
Otero, Miguel
Enhancement of Immune Responses by Guanosine-Based Particles in DNA Plasmid Formulations against Infectious Diseases
title Enhancement of Immune Responses by Guanosine-Based Particles in DNA Plasmid Formulations against Infectious Diseases
title_full Enhancement of Immune Responses by Guanosine-Based Particles in DNA Plasmid Formulations against Infectious Diseases
title_fullStr Enhancement of Immune Responses by Guanosine-Based Particles in DNA Plasmid Formulations against Infectious Diseases
title_full_unstemmed Enhancement of Immune Responses by Guanosine-Based Particles in DNA Plasmid Formulations against Infectious Diseases
title_short Enhancement of Immune Responses by Guanosine-Based Particles in DNA Plasmid Formulations against Infectious Diseases
title_sort enhancement of immune responses by guanosine-based particles in dna plasmid formulations against infectious diseases
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556318/
https://www.ncbi.nlm.nih.gov/pubmed/31240233
http://dx.doi.org/10.1155/2019/3409371
work_keys_str_mv AT santossaritza enhancementofimmuneresponsesbyguanosinebasedparticlesindnaplasmidformulationsagainstinfectiousdiseases
AT ramirezmaite enhancementofimmuneresponsesbyguanosinebasedparticlesindnaplasmidformulationsagainstinfectiousdiseases
AT mirandaeric enhancementofimmuneresponsesbyguanosinebasedparticlesindnaplasmidformulationsagainstinfectiousdiseases
AT reyesnelson enhancementofimmuneresponsesbyguanosinebasedparticlesindnaplasmidformulationsagainstinfectiousdiseases
AT martinezosmarie enhancementofimmuneresponsesbyguanosinebasedparticlesindnaplasmidformulationsagainstinfectiousdiseases
AT acostasantiagomaxier enhancementofimmuneresponsesbyguanosinebasedparticlesindnaplasmidformulationsagainstinfectiousdiseases
AT riverajosem enhancementofimmuneresponsesbyguanosinebasedparticlesindnaplasmidformulationsagainstinfectiousdiseases
AT oteromiguel enhancementofimmuneresponsesbyguanosinebasedparticlesindnaplasmidformulationsagainstinfectiousdiseases